|
Volumn 43, Issue 2, 2011, Pages 112-121
|
Safety and feasibility of combined granulocyte colony stimulating factor and erythropoetin based-stem cell therapy using intracoronary infusion of peripheral blood stem cells in patients with recent anterior myocardial infarction: one-year follow-up of a phase 1 study.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ERYTHROPOIETIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ELUTING STENT;
FEASIBILITY STUDY;
FEMALE;
HEALTH SURVEY;
HEART INFARCTION;
HEART LEFT VENTRICLE FUNCTION;
HEART STROKE VOLUME;
HUMAN;
MALE;
METHODOLOGY;
MIDDLE AGED;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
PHASE 1 CLINICAL TRIAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
TIME;
TRANSLUMINAL CORONARY ANGIOPLASTY;
AGED;
ANGIOPLASTY, BALLOON, CORONARY;
DRUG-ELUTING STENTS;
ERYTHROPOIETIN;
FEASIBILITY STUDIES;
FEMALE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HEALTH STATUS INDICATORS;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
PROSPECTIVE STUDIES;
STROKE VOLUME;
TIME FACTORS;
VENTRICULAR FUNCTION, LEFT;
|
EID: 84855724224
PISSN: 01259326
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (10)
|
References (0)
|